POLİFARMA

1986

OUR INCORPORATION

Polifarma was incorporated in Istanbul in 1986.

2007

POLYPROPYLENE INVESTMENT

New-generation PP bag technology was implemented with full automation.

2015

MARKET LEADER IN SERUM

Polifarma become the leader serum producer with its 50% market share on national basis.

2016

COOPERATION

We started to operate as one of the first 3 companies in Turkey providing domestic and foreign contract manufacturing services in accordance with the EU-GMP standards.

2016

ASEPTIC FIELD 1st PHASE INVESTMENT

Lyophilized vial and ampoule R&D activities were initiated.

2017

POL R&D

POL R&D was founded upon the approval of the Ministry of Science, Industry and Technology.

2018

ASEPTIC FIELD 2st PHASE INVESTMENT

Lyophilized vial and ampoule production was initiated in June.

2019

PARENTERAL FEEDING PROJECT

The production of the first domestic 3 chamber feeding solution in Turkey was initiated in the first quarter of the year.

2019

PERITONEAL DIALYSIS PROJECT

The production of the first domestic peritoneal dialysis device + solution in Turkey was completed and started to provide service to patients.

2019

READY-TO-USE INJECTION PROJECT

The production of the first ready-to-use injection was started.

2021

EU-GMP

Euro GMP approval.

2025

NEW PRODUCT RANGES

Biosimilar, biobetter and cytotoxic oncology products

POLİFARMA

1986

OUR INCORPORATION

Polifarma was incorporated in Istanbul in 1986.

2007

POLYPROPYLENE INVESTMENT

New-generation PP bag technology was implemented with full automation.

2015

MARKET LEADER IN SERUM

Polifarma become the leader serum producer with its 50% market share on national basis.

2016

COOPERATION

We started to operate as one of the first 3 companies in Turkey providing domestic and foreign contract manufacturing services in accordance with the EU-GMP standards.

2016

ASEPTIC FIELD 1st PHASE INVESTMENT

Lyophilized vial and ampoule R&D activities were initiated.

2017

POL R&D

POL R&D was founded upon the approval of the Ministry of Science, Industry and Technology.

2018

ASEPTIC FIELD 2st PHASE INVESTMENT

Lyophilized vial and ampoule production was initiated in June.

2019

PARENTERAL FEEDING PROJECT

The production of the first domestic 3 chamber feeding solution in Turkey was initiated in the first quarter of the year.

2019

PERITONEAL DIALYSIS PROJECT

The production of the first domestic peritoneal dialysis device + solution in Turkey was completed and started to provide service to patients.

2019

READY-TO-USE INJECTION PROJECT

The production of the first ready-to-use injection was started.

2021

EU-GMP

Certified by EU-GMP.

2025

NEW PRODUCT RANGES

Biosimilar, biobetter and cytotoxic oncology products